To support its activities, ICCBBA charges an annual license fee for the use of the ISBT 128 Standard. The annual license fee is based on the number of whole blood, apheresis, or cellular therapy units collected or by the number of final tissue products produced by a facility in the previous year.
That means if a participating facility collected 15,000 whole blood, apheresis, or cellular therapy products in a year, ICCBBA would receive US$184.50. For every 5,000 labeled tissues, ICCBBA would receive US$750.
Click here for license fee specifics.
Click here for ICCBBA's Annual Report to learn more about how your license fees are used.
ICCBBA expresses its deepest gratitude to all of our participating facilities, and to our team of volunteers, for their continuing support of the ISBT 128 Standard.